logo

For the Inventor, By the Inventor

Dallas, TX, United States of America

Access Pharmaceuticals, Inc.


USPTO Granted Patents = 16



Forward Citations = 730

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal David P Nowotnik (5 out of 16 patents)

silverMedal David F Ranney (5 out of 12 patents)

bronzeMedal Donald R Stewart (3 out of 4 patents)

4.  Paul R Sood (2 out of 5 patents)

5.  Mark B Knudson (2 out of 127 patents)

6.  Jeremy E Jacob (2 out of 2 patents)

7.  Christiane M Baud (2 out of 2 patents)

8.  Ruth Duncan (2 out of 11 patents)

9.  Sergiy Victorovych Shevchuk (2 out of 2 patents)

10.  Julio M Fernandez (2 out of 5 patents)

11.  Evagoras G Evagorou (2 out of 2 patents)

12.  Paolo Ferruti (1 out of 28 patents)

13.  Elisabetta Gianasi (1 out of 2 patents)

14.  Daniel G Moro (1 out of 4 patents)

15.  K Bruce Thurmond (1 out of 1 patent)


16 patents:

1. 7754684 - Macromolecular platinum chelates (2010-07-13),
2. 7547433 - Liquid formulations for the prevention and treatment of mucosal diseases and disorders (2009-06-16),
3. 7544348 - Liquid formulations for the prevention and treatment of mucosal diseases and disorders (2009-06-09),
4. 7166733 - O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes (2007-01-23),
5. 6692734 - N,O-amidomalonate platinum complexes (2004-02-17),
6. 6585997 - Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds (2003-07-01),
7. 6521431 - Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments (2003-02-18),
8. 6106866 - In vivo agents comprising cationic drugs, peptides and metal chelators (2000-08-22),
9. 5985916 - Polymer-platinum compounds (1999-11-16),
10. 5965118 - Polymer-platinum compounds (1999-10-12),
11. 5820879 - Method of delivering a lipid-coated condensed-phase microparticle (1998-10-13),
12. 5753261 - Lipid-coated condensed-phase microparticle composition (1998-05-19),
13. 5707604 - Vivo agents comprising metal-ion chelates with acidic saccharides and (1998-01-13),
14. 5672334 - Invivo agents comprising cationic metal chelators with acidic (1997-09-30),
15. 5336762 - Polychelating agents for image and spectral enhancement (and spectral (1994-08-09),
Access Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of proprietary products for the treatment and supportive care of cancer patients. The company's lead product is MuGard, an FDA-approved, alcohol-free, mucoadhesive oral wound rinse for the management of oral mucositis, a common side effect of chemotherapy and radiation therapy. Access Pharmaceuticals is dedicated to improving the quality of life for cancer patients through innovative drug delivery technologies.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

16 Patents

#124 in Dallas, TX

#1,196 in Texas

#19,312 in US

#36,684 in the World

...
Dallas, TX, United States of America

Access Pharmaceuticals, Inc.

Forward Citations = 730

22 inventors:

goldMedal David P Nowotnik (5 out of 16 patents)

silverMedal David F Ranney (5 out of 12 patents)

bronzeMedal Donald R Stewart (3 out of 4 patents)

4.  Paul R Sood (2 out of 5 patents)

5.  Mark B Knudson (2 out of 127 patents)

Please report any incorrect information to support@idiyas.com
Loading…